Press Releases

SAN FRANCISCO, Feb. 8, 2012 /PRNewswire-USNewswire/ -- There is growing evidence that supports an association between atypical fractures of the femur – a rare break of the thigh bone, typically without trauma – and the use of bisphosphonates, drugs proven to enhance bone density and reduce fracture incidence caused by osteoporosis. While the risk for suffering an atypical femur fracture while taking bisphosphonates is still very small – just 1 in 1,000 patients after six years of treatment – research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that discontinuing bisphosphonate use following an atypical femur fracture can significantly lower the risk for a subsequent atypical fracture.

Scientists believe that bisphosphonates may suppress the body's natural process of remodeling – where old bone tissue is replaced with new, healthy tissue – in some patients, resulting in brittle bones susceptible to atypical fractures, especially in the femur.

Investigators reviewed femur fracture data from Jan. 1, 2007 until Dec. 31, 2009 in patients older than 45 enrolled in a large California HMO. There were 126 patients with an atypical femur fracture who reportedly took bisphosphonates prior to their bone break.

The incidence of a subsequent atypical femur fracture occurring in the other thigh was 53.9 percent in patients who continued bisphosphonates for three or more years after their first fracture, compared to 19.3 percent in patients who discontinued bisphosphonate use. Overall, subsequent atypical femur fractures were decreased by 65.6 percent when bisphosphonates were stopped within one year following the first fracture.

"The risk of a contralateral atypical femur fracture (on the opposite side) increases over time if the bisphosphonates are continued," said lead investigator Richard Dell, MD, a researcher in the Department of Orthopaedics at Kaiser Permanente. "Based on these observations, we recommend discontinuing bisphosphonate use as soon as possible after the initial atypical femur fracture has occurred."  

Dr. Dell then recommends the ongoing evaluation of these patients, through X-ray or MRI, as they still are at risk for a subsequent, atypical femur fracture on the other femur.

If the patient is at high risk for other fractures, the study recommends use of an alternative osteoporosis medication.

Disclosure:  The author of this study does not have anything related to disclose.

Study Abstract

About  AAOS

Follow us on Facebook.com/AAOS1 and Twitter.com/AAOS1

For more information on bone and joint health, visit Orthoinfo.org.

SOURCE American Academy of Orthopaedic Surgeons

EMERYVILLE, Calif., Feb. 8, 2012 /PRNewswire/ -- MobiTV, Inc., a leading provider of managed mobile TV and video solutions, today announced the appointment of Paul Burmester to the role of general manager and senior vice president for EMEA. Burmester's appointment demonstrates MobiTV's commitment to its expansion in the EMEA market.

"Paul brings experience in, and understanding of, the European technology industry, as well as relationships with top-tier mobile operators," said MobiTV CEO Charlie Nooney. "We're confident that he will continue to build the strong commercial relationships necessary for MobiTV to pursue expansion in the international market."

Burmester brings over 30 years of experience in the technology industry, most recently coming from senior positions within companies operating in the mobile sector. Burmester intends to build on MobiTV's proven success in North America, applying his product and business development expertise to define and pursue the company's market expansion strategy.

"MobiTV's success in North America is well established," said Burmester. "I look forward to working with the team at MobiTV to replicate this success in EMEA by offering their services to allow customers to deliver television and video anywhere, anytime on any device to users internationally."

About MobiTV, Inc.

Founded in 2000, MobiTV, Inc. is a leading provider of comprehensive managed services that deliver live and on-demand television and related media content across mobile devices, tablets, personal computers and other Internet-enabled consumer electronics. MobiTV is the exclusive national provider of mobile television services for AT&T U-verse Live TV, NFL Mobile on Verizon, Sprint TV, T-Mobile TV, Telus Mobile TV and US Cellular Mobile TV, among others. MobiTV's proprietary converged media platform is quick to deploy and easy to integrate with customers' existing systems and networks. The TV Everywhere solution, available nationally and internationally, allows the company to efficiently and reliably deliver high-quality television and video solutions anytime, anywhere, on any device.

For further information please contact: Andy Kill for MobiTV, Inc.Email: kill@airfoilpr.com Phone: 650.691.7311

Katharine Simon at Babel PR for MobiTV, Inc. Europe:Email: Katharine@babelpr.com Phone: +44 (0)207 434 5550

SOURCE MobiTV, Inc.

VANCOUVER, Wash., Feb. 8, 2012 /PRNewswire/ -- Today Wacom®, the leading manufacturer of pen tablets and interactive pen displays, announces a partnership with Access, a global provider of electronic forms management, automation and workflow software, to create a new e-Signature solution for the healthcare industry. The solution combines a Wacom signature tablet with Access' Intelligent Forms Suite software to deliver a more streamlined, secure and efficient way to integrate electronic handwritten signatures into the healthcare industry's daily workflow.

By bringing accurate and real life e-Signatures to the patient registration and bedside consent processes, Wacom and Access' solution reduces the time and cost previously invested in the process.

"Collecting traditional, hand-written signatures from patients at registration and bedside requires the use of paper forms, which not only incur high financial, productivity and environmental costs, but delay admission and inhibit information sharing," said Cody Strate, Sales Director. "With Wacom and Access's e-Signature solution, healthcare professionals and patients experience a reduction in the time and cost it takes to securely authorize medical appointments, exams and procedures."

Additionally, each one of Wacom's battery-free and cordless signature tablets is able to capture the static and biometric information of individual signatures which Access captures and binds to the document, providing an effective defense against fraud for both patients and healthcare providers. Litigation risk is also reduced with accurate, electronically-stored signatures proving patient consent.

"Through modernizing the signature capture process, Wacom and Access' e-Signature solution provides not only a cost-savings to healthcare providers with less of a need to print, scan and store documents, but an increase in the trust and confidence patients feel in their healthcare provider through the streamlined and professional process it offers," says Michael Marcum, Vice President of Vertical Markets for Wacom Technology Services, Corp. "Improving the process to add unalterable and legally-binding electronic signatures to documents is also a time-savings, which benefits both patients and the healthcare industry."

Wacom and Access will be showcasing their e-Signature solution at the Healthcare Information and Management System Society's Annual Conference (HIMSS) February 20-24 in Las Vegas. To learn more, please stop by:

Wacom's Booth Number: 13522

Access' Booth Number: 860

Resellers and System Integrators interested in selling Wacom and Access' e-Signature solution can send inquiries to SignatureTablet@wacom.com for more information.

About Wacom

Founded in 1983, Wacom's vision to bring people and technology closer together through natural interface technologies has made it the world's leading manufacturer of pen tablets, interactive pen displays and digital interface solutions. The advanced technology of Wacom's intuitive input devices provide business, education and healthcare users with the ability to explore digital content creation in a comfortable, natural way. For additional information, visit: http://www.wacom.com. 

About Access

Access is the world's leading electronic forms (e-forms) management, automation and workflow software provider. Our solutions transform any paper-intensive forms process into a paperless, collaborative workflow. Hundreds of hospitals worldwide are using Access solutions to improve patient care and safety, cut costs and enhance electronic health records (EHR), patient safety and downtime planning initiatives. Learn more at http://www.accessefm.com.

For more information, please contact:

Brooke DaleLiaison PR503.796.9822 brooke@liaisonpr.com

SOURCE Wacom Technology Services, Corp.

NEW YORK, Feb. 8, 2012 /PRNewswire/ -- The recipient of Market Watch's 2011 Spirits Brand of the Year, CIROC Ultra Premium today announces the newest addition to its flavor portfolio – CIROC PEACH. This new line extension joins CIROC Vodka, CIROC RED BERRY and CIROC COCONUT, providing consumers with not only the reassurance of quality in their flavored spirits, but also an offering that is infused with natural fruit flavors.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/sean-diddy-combs-and-the-makers-of-ciroc-ultra-premium-vodka-launch-ciroc-peach-138901034.html

With its robust introduction during New Year's Eve celebrations in New York, Los Angeles, Chicago, Houston, Miami and other select markets across the nation, CIROC PEACH has already paved its way in the lifestyle marketplace as the next "hot" variant.  Working with top tier mixologists, the brand has created specialty drink offerings including the Peach Bellini, White Peach, and Black Peach. The liquid features a refined and dulcet taste and will be featured in the weeks to come at high profile events surrounding Fashion Week in New York, Oscar and Grammy weekends in Los Angeles, as well as events during basketball's All-Star week in Orlando, FL. Consumers can also enjoy CIROC PEACH at top restaurants, bars and lounges throughout the U.S. 

"We revolutionized the industry with the introduction of CIROC RED BERRY and CIROC COCONUT, this time we plan to make an even bigger impact.  I'm excited to announce the launch of CIROC PEACH, the newest addition to our family of flavors and a surefire winner. Early results from select markets across the country show that consumers really enjoy the fresh, succulent flavor of Peach. CIROC PEACH is guaranteed to be a game changer," states Sean "Diddy" Combs.

CIROC PEACH features the scent of sun-ripened fresh peaches and delivers a succulent peach flavor with a hint of orchard fruits for a velvety, fresh and clean finish. Launching nationally on Feb 8, 2012, CIROC PEACH will be available in 50mL, 200mL, 375mL, and 750 mL, along with 1L and 1.75L sizes. The new flavor will be available to consumers at the suggested retail price of $34.99 for a 750mL bottle. The specialty spirit is 70 proof and 35% ABV. The makers of CIROC remind consumers to celebrate life responsibly.

CIROC PEACH CocktailsCIROC Peach Bellini1.25 oz CIROC PEACHFill to the top with chilled champagneCIROC White Peach 1.5 oz CIROC PEACH1.5 oz Ginger Ale CIROC Black Peach1.5 oz CIROC PEACH.75 oz PineappleSplash of Hennessy

About CIROC Ultra Premium Vodka

CIROC Ultra Premium Vodka is made using French Mauzac Blanc and Ugni Blanc grapes, which are distilled five times, providing a crisp, clean taste and citrus nose. CIROC launched nationwide in September 2003.  In October 2007, DIAGEO - the world's largest spirits, wine and beer company - made spirits history by entering into a strategic alliance with entertainment entrepreneur Sean "Diddy" Combs, in which Mr. Combs and Combs Enterprises assumed the lead on all brand management activities for CIROC. The makers of CIROC Vodka launched two new flavors - CIROC RED BERRY and CIROC COCONUT - in February 2010 and introduced CIROC PEACH regionally in October 2011, nationally in February 2012. All three are also made with vodka distilled from fine French grapes, and infused with natural coconut, wild berry, peach and other tropical/fruit flavors. In September 2011 Market Watch Leaders recognized CIROC as 'Spirits Brand of the Year' for its outstanding performance and unprecedented growth during the 2010 fiscal year. © 2012 Imported from France by DIAGEO, Norwalk, CT.   

Media Contact:Ben RussoEMC|BOWERY323.656.2030Ben@emcbowery.com  Tammy ThompsonDiageo203.229.4876Tammy.Thompson@diageo.com  Ryan StenderBlue Flame Agency917.449.2447Rstender@blueflame.us.com

SOURCE CIROC Ultra Premium Vodka